MFS Intercorp Limited has announced the successful completion of its postal ballot process, with shareholders approving two significant special resolutions that will reshape the company's capital structure. The voting process concluded on March 01, 2026, with the company officially disclosing the voting results on March 03, 2026, under Regulation 44 of SEBI Listing Regulations.

Postal Ballot Overview

The postal ballot was conducted with a record date of January 23, 2026, covering 3858 total shareholders on record. The voting period commenced at 10:00 A.M. on Friday, January 30, 2026, and concluded at 05:00 P.M. on Sunday, March 01, 2026. Ankurkumar Dineshchandra Gandhi of Ankur Gandhi & Associates served as the scrutinizer for the postal ballot process.

Resolution Results

Both special resolutions received identical voting patterns, with strong majority support from participating shareholders. The voting was conducted entirely through electronic means, with no physical postal ballots received.

Resolution 1: Authorized Share Capital Increase

The first resolution concerning increase in authorized share capital and consequent alteration of memorandum of association received overwhelming support with 76.05% votes in favor.

Resolution 2: Convertible Warrants Issuance

The second resolution for issuance of convertible warrants on a preferential basis received identical shareholder approval, also securing 76.05% votes in favor.

Shareholder Participation Analysis

The postal ballot saw participation from public non-institutional shareholders, who held 4321600 shares and polled 1622595 votes, representing 37.5462% of their holdings. Public institutional shareholders holding 3300 shares did not participate in the voting process. Notably, promoter and promoter group participation was zero across both resolutions.

Regulatory Compliance

The postal ballot process was conducted in accordance with Section 110 and 108 of the Companies Act, 2013, along with relevant rules and SEBI listing regulations. The company disclosed the voting results under Regulation 44 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, ensuring full regulatory compliance and transparency for all stakeholders. Director Kiran Vishwakarma (DIN: 10526319) signed the official disclosure documents on March 03, 2026.

MFS Intercorp Limited has secured in-principle approval from BSE Limited for its planned fundraising through preferential warrant issuance. The company announced this development through a regulatory filing dated 20.02.2026, marking a significant step forward in its capital raising initiative.

BSE Approval Details

The stock exchange granted its approval through a letter dated 19.02.2026, authorizing the company to proceed with raising funds through the issuance of warrants on a preferential basis. This approval represents a crucial regulatory milestone for the company's fundraising plans.

Regulatory Compliance Framework

The approval follows MFS Intercorp's systematic approach to regulatory compliance. The company had previously submitted necessary documentation on 29.01.2026, followed by a corrigendum dated 16.02.2026. These submissions were made in adherence to applicable provisions under multiple regulatory frameworks.

The fundraising initiative is being conducted in compliance with:

• Companies Act, 2013
• Chapter V of SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018
• SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015

Company Information

MFS Intercorp Limited operates with its registered office located at Office No.5, 1st Floor BLK B, PKT 3, Se 34, Rohini, New Delhi 110042. The company maintains its corporate office at 109 First Floor, Arista, Bodakdev, Ahmedabad, Gujarat, India, 380054. The regulatory filing was signed by Director Kiran Vishwakarma (DIN: 10526319) from the company's Ahmedabad location.

The in-principle approval from BSE represents an important step in the company's capital raising process, enabling it to move forward with the preferential warrant issuance subject to fulfilling remaining regulatory requirements.